{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:49:45Z","timestamp":1785401385576,"version":"3.56.0"},"reference-count":52,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Viral hepatitis is the main cause of infectious liver disease. During pregnancy, a risk of vertical transmission exists both during gestation and at birth. HAV, HBV, and HCV might progress similarly in pregnant and non-pregnant women. In this study, we found a prevalence of 0.22% of viral hepatitis in pregnant women, with a light preponderance of HCV over HAV and HBV. Here, it was observed that acute HAV infection is more symptomatic and has higher risks for the mother and fetus, in a similar manner to what has been reported for HEV. Histopathological alterations were observed in all except one placenta, indicating that it is an important tissue barrier. Regarding the Mexican strategies for viral hepatitis eradication, success may be related to vaccination at birth, whereas for HCV, the national program for eradication is aimed at treating the infection via direct-acting antiviral agents. The HBV strategy has positively impacted pregnant women and their children, diminishing the risk of vertical transmission. The HCV strategy is still in its early years, and it is expected to be just as successful. For acute hepatitis, HAV and HEV, programs promoting hand washing and those aimed at providing clean food and water are applicable as preventive strategies, alongside other programs such as vaccination.<\/jats:p>","DOI":"10.3390\/pathogens13080651","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T09:34:17Z","timestamp":1722591257000},"page":"651","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Viral Hepatitis in Pregnant Mexican Women: Its Impact in Mother\u2013Child Binomial Health and the Strategies for Its Eradication"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-9975","authenticated-orcid":false,"given":"Carmen Selene","family":"Garc\u00eda-Romero","sequence":"first","affiliation":[{"name":"Departamento de Infectolog\u00eda e Inmunolog\u00eda, Instituto Nacional de Perinatolog\u00eda Isidro Espinosa de los Reyes, Mexico City 11000, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7658-045X","authenticated-orcid":false,"given":"Carolina","family":"Guzm\u00e1n","sequence":"additional","affiliation":[{"name":"Laboratorio de H\u00edgado, P\u00e1ncreas y Motilidad, Unidad de Medicina Experimental, Hospital General de M\u00e9xico Dr. Eduardo Liceaga, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-7933","authenticated-orcid":false,"given":"Alejandra","family":"Mart\u00ednez-Ibarra","sequence":"additional","affiliation":[{"name":"Facultad de Qu\u00edmica, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City 04960, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Cervantes","sequence":"additional","affiliation":[{"name":"Servicio de Gen\u00e9tica, Hospital General de M\u00e9xico Dr. Eduardo Liceaga, Mexico City 06720, Mexico"},{"name":"Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City 04960, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cerb\u00f3n","sequence":"additional","affiliation":[{"name":"Facultad de Qu\u00edmica, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City 04960, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41575-020-00361-w","article-title":"Viral hepatitis and pregnancy","volume":"18","author":"Terrault","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3748\/wjg.v27.i16.1691","article-title":"From hepatitis A to E: A critical review of viral hepatitis","volume":"27","author":"Castaneda","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.3748\/wjg.v27.i26.4018","article-title":"Viral hepatitis update: Progress and perspectives","volume":"27","author":"Pisano","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tseligka, E.D., Cl\u00e9ment, S., and Negro, F. (2021). HDV Pathogenesis: Unravelling Ariadne\u2019s Thread. Viruses, 13.","DOI":"10.3390\/v13050778"},{"key":"ref_5","unstructured":"SSA, DGE, and DVEENT (2020). Informe Anual de Vigilancia Epidemiol\u00f3gica de Hepatitis Virales, M\u00e9xico 2020, Direcci\u00f3n General de Epidemiolog\u00eda."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Viera-Segura, O., Calder\u00f3n-Flores, A., Bat\u00fan-Alfaro, J.A., and Fierro, N.A. (2023). Tracing the History of Hepatitis E Virus Infection in Mexico: From the Enigmatic Genotype 2 to the Current Disease Situation. Viruses, 15.","DOI":"10.3390\/v15091911"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Maekawa, S., Takano, S., and Enomoto, N. (2024). Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment. J. Formos. Med. Assoc., in press.","DOI":"10.1016\/j.jfma.2024.01.015"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/cld.1079","article-title":"Viral Hepatitis in Pregnancy: An Update on Screening, Diagnosis, and Management","volume":"18","author":"Sanghi","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.aohep.2019.04.009","article-title":"Liver disease in pregnancy: Medical aspects and their implications for mother and child","volume":"18","author":"Guzman","year":"2019","journal-title":"Ann. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1038\/s41467-018-07200-2","article-title":"Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface","volume":"9","author":"Gouilly","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12985-020-01343-9","article-title":"Hepatitis E virus infection during pregnancy","volume":"17","author":"Wu","year":"2020","journal-title":"Virol. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/S0036-36342003000300005","article-title":"Seroprevalence of hepatitis B in pregnant women in Mexico","volume":"45","author":"Attlan","year":"2003","journal-title":"Salud Publica Mex."},{"key":"ref_13","unstructured":"WMA (2024, July 23). WMA Declaration of Helsinki\u2014Ethical Principles for Medical Research Involving Human Subjects. WMA\u2013The World Medical Association, Available online: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"ACOG (2023). Viral Hepatitis in Pregnancy: ACOG Clinical Practice Guideline No. 6. Obstet. Gynecol., 142, 745\u2013759.","DOI":"10.1097\/AOG.0000000000005300"},{"key":"ref_15","unstructured":"IMSS (2022). Atenci\u00f3n y cuidados multidisciplinarios en el embarazo. Gu\u00eda de Pr\u00e1ctica Cl\u00ednica: Evidencias y Recomendaciones, Intituto Mexicano del Seguro Social."},{"key":"ref_16","unstructured":"SSA, and CENSIDA (2022). Gu\u00eda de hepatitis virales para establecimientos de salud. La Hepatitis es Curable, Centro Nacional para la Prevenci\u00f3n y el Control del VIH y el SIDA."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejogrb.2020.11.052","article-title":"Viral Hepatitis in pregnancy","volume":"256","author":"Chilaka","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1053\/j.gastro.2006.01.007","article-title":"Acute Hepatitis A Infection in Pregnancy Is Associated with High Rates of Gestational Complications and Preterm Labor","volume":"130","author":"Elinav","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jvh.13725","article-title":"Viral hepatitis in pregnancy","volume":"29","author":"Shata","year":"2022","journal-title":"J. Viral Hepat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ajog.2021.09.002","article-title":"Treatment and prevention of viral hepatitis in pregnancy","volume":"226","author":"Cozzi","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_21","first-page":"963","article-title":"Hepatitis A infection during pregnancy","volume":"61","author":"Chaudhry","year":"2015","journal-title":"Can. Fam. Physician"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cld.2018.06.002","article-title":"Hepatitis B and C","volume":"22","author":"Mysore","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2147\/JHC.S384751","article-title":"Molecular and clinical features of hepatocellular carcinoma in patients with HBV-HDV infection","volume":"10","author":"Costante","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12072-017-9831-0","article-title":"Mother-to-infant transmission of hepatitis B virus: Challenges and perspectives","volume":"11","author":"Shih","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Lu, H., Cao, W., Zhang, L., Yang, L., Bi, X., Lin, Y., Deng, W., Jiang, T., Sun, F., and Zeng, Z. (2023). Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1122048"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.biologicals.2017.08.008","article-title":"Eradicating hepatitis B virus: The critical role of preventing perinatal transmission","volume":"50","author":"Stevens","year":"2017","journal-title":"Biologicals"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3109\/14767058.2013.806901","article-title":"Breast feeding and immunoprophylaxis efficacy of mother-to-child transmission of hepatitis B virus","volume":"27","author":"Zhang","year":"2014","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s12072-021-10235-1","article-title":"Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load","volume":"15","author":"Li","year":"2021","journal-title":"Hepatol. Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"106726","DOI":"10.1016\/j.ijantimicag.2023.106726","article-title":"Low levels of tenofovir in breast milk support breastfeeding in HBV-infected mothers treated with tenofovir disoproxil fumarate","volume":"61","author":"Li","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1080\/14787210.2022.2125868","article-title":"Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV)","volume":"20","author":"Eke","year":"2022","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000096306","article-title":"Low prevalence of anti-hepatitis C virus antibodies in Mexico: A systematic review","volume":"50","author":"Chiquete","year":"2007","journal-title":"Intervirology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Dom\u00ednguez-Rodr\u00edguez, S., Prieto, L., Fern\u00e1ndez McPhee, C., Ill\u00e1n-Ramos, M., Beceiro, J., Escosa, L., Mu\u00f1oz, E., Olabarrieta, I., Regidor, F.J., and Roa, M.\u00c1. (2020). Perinatal HCV transmission rate in HIV\/HCV coinfected women with access to ART in Madrid, Spain. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0230109"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11904-022-00643-9","article-title":"Evidence for implementation: HIV\/HCV coinfection and pregnancy","volume":"20","author":"Curtis","year":"2023","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"E2324770","DOI":"10.1001\/jamanetworkopen.2023.24770","article-title":"Trends in the prevalence of hepatitis C infection during pregnancy and maternal-infant otcomes in the US, 1998 to 2018","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100292","DOI":"10.1016\/j.aohep.2020.100292","article-title":"A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico-A systematic review and meta-analysis (2008\u20132019)","volume":"20","author":"Panduro","year":"2021","journal-title":"Ann. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.3748\/wjg.v26.i37.5543","article-title":"Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment","volume":"26","author":"Aslan","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/jmv.24878","article-title":"Low prevalence of IgG antibodies against antigens of HEV genotypes 1 and 3 in women with a high-risk pregnancy","volume":"89","year":"2017","journal-title":"J. Med. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"a032136","DOI":"10.1101\/cshperspect.a032136","article-title":"Natural history, clinical manifestations, and pathogenesis of hepatitis E virus genotype 1 and 2 Infections","volume":"9","author":"Aggarwal","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jceh.2013.05.010","article-title":"Hepatitis e: Epidemiology and natural history","volume":"3","author":"Aggarwal","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/liv.15468","article-title":"Severe maternal\u2013fetal pathological damage and inflammatory responses contribute to miscarriage caused by hepatitis E viral infection during pregnancy","volume":"43","author":"Xia","year":"2023","journal-title":"Liver Int."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Wen, G.P., Wang, M.M., Tang, Z.M., Liu, C., Yu, Z.H., Wang, Z., Zheng, Z.Z., Zhou, Y.L., and Ge, Y.S. (2023). Prevalence of hepatitis E virus and its associated outcomes among pregnant women in China. Pathogens, 12.","DOI":"10.3390\/pathogens12091072"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1665-2681(19)31250-5","article-title":"Hepatitis E virus exposure in pregnant women in rural Durango, Mexico","volume":"13","year":"2014","journal-title":"Ann. Hepatol."},{"key":"ref_44","first-page":"1904","article-title":"Hepatitis E virus infection increases the risk of obstetric complications and perinatal adverse outcomes in pregnant women with chronic hepatitis B virus infection","volume":"28","author":"Chen","year":"2024","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Lee, J.K., Oh, S.J., Park, H., and Shin, O.S. (2019). Recent updates on research models and tools to study virus-host interactions at the placenta. Viruses, 12.","DOI":"10.3390\/v12010005"},{"key":"ref_46","first-page":"278","article-title":"Relationship between the immunohistopathological changes of hepatitis B virus carrier mothers\u2019 placentas and fetal hepatitis B virus infection","volume":"37","author":"Liu","year":"2002","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Narang, K., Cheek, E.H., Enninga, E.A.L., and Theiler, R.N. (2021). Placental immune responses to viruses: Molecular and histo-pathologic perspectives. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062921"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1080\/21645515.2015.1010890","article-title":"An \u201cimmune barrier\u201d is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother","volume":"11","author":"Liu","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jmv.2187","article-title":"Risk factors and mechanism of transplacental transmission of hepatitis B virus: A case-control study","volume":"67","author":"Xu","year":"2002","journal-title":"J. Med. Virol."},{"key":"ref_50","unstructured":"(2024, July 01). IMSS Gu\u00eda de Referencia R\u00e1pida Vacunaci\u00f3n en la Embarazada. Available online: https:\/\/www.imss.gob.mx\/sites\/all\/statics\/guiasclinicas\/580GRR.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"314","DOI":"10.18233\/APM39No5pp314-3191679","article-title":"Vacunaci\u00f3n durante el embarazo","volume":"39","year":"2018","journal-title":"Acta Pedi\u00e1trica M\u00e9xico"},{"key":"ref_52","unstructured":"(2021). CENSIDA (Standard No. SSA). Available online: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/649433\/Bolet_n_VHC_Vol_2_N_2.pdf."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/8\/651\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:28:42Z","timestamp":1760110122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/8\/651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["pathogens13080651"],"URL":"https:\/\/doi.org\/10.3390\/pathogens13080651","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}